Data showed that after cerebral ischemia and GTA treatment, C75 didn’t affect the protein level of FASN (Fig. 5 A, B), while FASN shRNA decreased the protein level of FASN in astrocytes in the peri-infarct area (Fig. 5 A, B, P < 0.01). This evidence concerns the gene FASN and brain ischemia.